N/A N=67 Outcomes of Compliance With Brace Wear in Clubfoot
Clubfoot
Primary: Wear Rate Percentage (Number of Hours Per Day Brace Was Worn Out of the Recommended 24 Hours) — 91.7; NA; NA; 86.8 percentage of time worn
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=153 Non-compliance on Treatment Among Diabetic Students at Sohag University
Diabetes Mellitus, Type 1
Primary: Distribution of Participants Responses as Regards DSMQ Glucose Management Domain — 13; 56; 39; 45 Participants
N/A N=375 Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Dyslipidemia
Primary: Percentage of Participants Who Were Compliant With Statin Treatment — 86.7 Percentage of participants
N/A N=60 Smart Capsule for Automatic Adherence Monitoring
Medication Adherence
Primary: Medication Adherence — 88.1; 96.6; 94.4 percentage of doses taken (pill count)
N/A N=124 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA
Premature Infants
Primary: Number of Injections Per Patient Per Season — 3.8; 3.9; 4.0; 1.0 Injections administered
N/A N=48 Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
Obstructive Sleep Apnea
Primary: Group Compliance of the Auto Bilevel Group Compared to the CPAP Group Measured by Average Nightly Use. — 284.7; 255.1 minutes/night — p=0.377
N/A N=19 Technology-Enhanced Helping the Noncompliant Child
Child Externalizing Behavior
Primary: Retention — 8; 7 Participants
N/A N=72 Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
Smokers
Primary: Percent Compliance With Chantix — 90.7; 85.8; 87.1; 91.7 Percentage of Participants
N/A N=257 Compliance With Treatment For Patients With Hyperlipidemia
Hyperlipidemia
Primary: Percentage of Participants With Positive Response on Increased Motivation Using a Self-test at Month 12 — 36.2 Percentage of participants
Phase 4 N=154 Self-management of Low Molecular Weight Heparin Therapy
Thromboembolism
Primary: Drug Use Problems — 1.25; 0.86; 1.20; 1.17 scores on a scale
N/A N=245 Effect of Compliance Counseling on Brace Success in Patients With Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
Primary: Brace Progress Report (i.e. Informing the Patient How Often They Were Wearing the Brace Versus Not Informing the Patient) — 93; 78; 26; 29 participants
N/A N=294 Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)
Hepatitis C, Chronic · Hepatitis C
Primary: Number of Participants Who Are Triple-80 Compliant — 183 Participants
N/A N=20 Evaluation of a Program to Enhance Ophthalmic Compliance in Children and Adolescents With Special Needs
Visual Rehabilitation · Visual Impairment, Autism Spectrum Disorder, Developmental Disabilities, Intellectual Disability, Behavioral Symptoms
Primary: Visual Function Battery for Children With Special Needs (VFB-CSN) — 45.00; 48.21 score — p=0.008
N/A N=40 Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
Medication Adherence
Primary: Medication Adherence — 94.8; 82.8 percentage of doses taken
Phase 4 N=262 Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia
Dyspepsia · Compliance · Depression
Primary: Compliance of Flupentixol-Melitracen — 44; 28; 31 participants